...was VP of pharmaceutical sciences and Polyakova was the protein and molecular group lead at GammaDelta Therapeutics Ltd....
...growth officer from chief marketing officer. Robin Sawka, BioCentury Staff BioCentury Staff Genmab A/S Tricida Inc. Akcea Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo...

...the University of Texas MD Anderson Cancer Center. There is growing competition in the space. GammaDelta Therapeutics Ltd....

...CEOs included device companies, the public sector and the healthcare divisions of larger technology companies. GammaDelta Therapeutics Ltd....
...you go back to that,” she said. Karen Tkach Tuzman, Associate Editor Atlas Venture Venrock Agios Pharmaceuticals Inc. Nuvelution Pharma Inc. GammaDelta Therapeutics Ltd. management first-time...

...TCR against a virus that causes adult T cell leukemia and lymphoma (No. 3216) . GammaDelta Therapeutics Ltd....

...Sciences Inc. (NASDAQ:GILD), bought a substantial stake in Gadeta, with an option to buy. U.K.-based GammaDelta Therapeutics Ltd....
...chairman. Targets: BTN2A - butyrophilin 2A; BTN3A - butyrophilin 3A Val Kennedy, Associate Editor ImCheck Therapeutics S.A.S. Gadeta B.V. GammaDelta Therapeutics Ltd. Pfizer...

...time-limited option to acquire Adaptate Biotherapeutics Ltd. and has provided undisclosed funding, along with Abingworth. GammaDelta Therapeutics Ltd....
...quarter and to select its lead target in the next 12-18 months. Elizabeth S. Eaton, Staff Writer GammaDelta Therapeutics Ltd. Takeda...

...in areas that themselves are new. For example, Takeda entered a build-to-buy deal with newco GammaDelta Therapeutics Ltd....
...received an option exercise and upfront payment, and is eligible for milestones plus royalties. 9/4/17 GammaDelta Therapeutics Ltd....
...Ltd., Cambridge, U.K. Curadev Pharma Pvt. Ltd., Noida, India Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan GammaDelta Therapeutics Ltd....

...while build-to-buys have historically been more common for single-asset or single-target companies pursuing traditional modalities, GammaDelta Therapeutics Ltd.’s...
...Crescendo Biologics Ltd., Cambridge, U.K. Francis Crick Institute, London, U.K. Gadeta B.V., Utrecht, the Netherlands GammaDelta Therapeutics Ltd....
...Ltd., Holytown, U.K. Targets MICA - MHC class I polypeptide-related sequence A Karen Tkach Tuzman, Associate Editor GammaDelta Therapeutics Ltd. Takeda...

...Capital founded Maverick in 2016. Then in May 2017, Takeda gained an option to acquire GammaDelta Therapeutics Ltd....
...flexibility to pursue more radical ideas.” Companies and Institutions Mentioned Ambys Medicines, Redwood City, Calif. GammaDelta Therapeutics Ltd....

...TEG001 next quarter and submit an IND for TEG002 in 2020, Margetson said. Last year, GammaDelta Therapeutics Ltd....
...Gadeta B.V., Utrecht, the Netherlands Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Cancer Allison Johnson Gadeta B.V. GammaDelta Therapeutics Ltd. Gilead...